NRIX Nurix Therapeutics, Inc.
$23.34
Nurix Therapeutics, Inc. (NRIX) Earnings News
Earnings press releases, previews and reviews for Nurix Therapeutics, Inc. (NRIX), newest first.
Thursday
July 9, 2026
4:01 PM ET
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Thursday
June 11, 2026
7:00 AM ET
Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy
Wednesday
April 8, 2026
6:00 AM ET
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update